Antioxidant Therapy in Hemodialysis Patients

Document Type : Letter to Editor

Authors

1 Professor, Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran

2 Resident, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Cardiovascular problem is the major cause of mortality and morbidity in patients under hemodialysis for chronic kidney disease. Increased lipid peroxidation and depletion of chain-breaking antioxidants may be related to increased risk of atherosclerosis. Oxidative stress and acute phase inflammation are now defined to be highly prevalent in the hemodialysis patients, and several lines of evidence point to their contribution in atherosclerosis development. Antioxidants have been used as therapies to decrease oxidative stress and improve risk of cardiovascular diseases (CVD) in hemodialysis patients. However, plants and fruits antioxidants are reliable ones. Probably, because plants antioxidants are a mixture of several substances with antioxidant activity, which each one supports the other one.

  1. Coombes JS, Fassett RG. Antioxidant therapy in hemodialysis patients: a systematic review. Kidney Int 2012; 81(3): 233-46.
  2. Gheshlaghi F. Toxic renal injury at a glance. J Ren Inj Prev 2012; 1(1): 15-6.
  3. Cozma LS. The role of antioxidant therapy in cardiovascular disease. Curr Opin Lipidol 2004; 15(3): 369-71.
  4. Nasri H. Acute kidney injury and beyond. J Ren Inj Prev 2012; 1(1): 1-2.
  5. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995; 41(8 Pt 1): 1135-8.
  6. Rafieian-Kopaei M, Baradaran A. Combination of metformin with other antioxidants may increase its renoprotective efficacy. J Ren Inj Prev 2013; 2(2): 35-6.
  7. Khajehdehi P. Turmeric: Reemerging of a neglected Asian traditional remedy. J Nephropathol 2012; 1(1):17-22.
  8. Rouhi H, Ganji F. Effects of N-acetyl cysteine on serum lipoprotein (a) and proteinuria in type 2 diabetic patients. J Nephropathol 2012; 2(1): 61-6.
  9. Gobe C, Morais C, Vesey A, Johnson W. Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney. J Nephropathol 1970; 2(3): 154-65.
  10. Behradmanesh S, Nasri P. Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients. J Ren Inj Prev 2012; 1(1): 23-6.
  11. Sahni N, Gupta KL. Dietary antioxidants and oxidative stress in predialysis chronic kidney disease patients. J Nephropathol 2012; 1(3): 134-42.
  12. Ziouzenkova O, Asatryan L, Tetta C, Wratten ML, Hwang J, Sevanian A. Oxidative stress during ex vivo hemodialysis of blood is decreased by a novel hemolipodialysis procedure utilizing antioxidants. Free Radic Biol Med 2002; 33(2): 248-58.
  13. Nasri H, Nematbakhsh M, Ghobadi S, Ansari R, Shahinfard N, Rafieian-Kopaei M. Preventive and curative effects of ginger extract against histopathologic changes of gentamicin-induced tubular toxicity in rats. Int J Prev Med 2013; 4(3): 316-21.
  14. Ghorbani A, Omidvar B, Parsi A. Protective effect of selenium on cisplatin induced nephrotoxicity: A double-blind controlled randomized clinical trial. J Nephropathol 2013; 2(2): 129-34.
  15. Rafieian-Kopaei M, Baradaran A, Rafieian M. Plants antioxidants: From laboratory to clinic. J Nephropathol 2013; 2(2): 152-3.
  16. Tavafi M. Diabetic nephropathy and antioxidants. J Nephropathol 2012; 2(1): 20-7.
  17. Rafieian-Kopaei M, Baradaran A, Merrikhi A, Nematbakhsh M, Madihi Y, Nasri H. Efficacy of Co-administration of Garlic Extract and Metformin for Prevention of Gentamicin-Renal Toxicity in Wistar Rats: A Biochemical Study. Int J Prev Med 2013; 4(3): 258-64.
  18. Tavafi M. Protection of renal tubules against gentamicin induced nephrotoxicity. J Ren Inj Prev 2012; 2(1): 5-6.